These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8957064)

  • 21. Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients.
    Müller P; Ostwald C; Püschel K; Brinkmann B; Plath F; Kröger J; Barten M; Nizze H; Schareck WD; Hauenstein K; Liebe S; Löhr JM
    Eur J Clin Invest; 2001 Mar; 31(3):240-7. PubMed ID: 11264652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis.
    Nagao T; Sugano I; Ishida Y; Asoh A; Munakata S; Yamazaki K; Konno A; Iwaya K; Shimizu T; Serizawa H; Ebihara Y
    Mod Pathol; 2002 Jul; 15(7):724-33. PubMed ID: 12118110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
    Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients.
    Hsu HC; Peng SY; Lai PL; Sheu JC; Chen DS; Lin LI; Slagle BL; Butel JS
    Cancer; 1994 Jan; 73(1):42-7. PubMed ID: 7506118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features.
    Papotti M; Sambataro D; Marchesa P; Negro F
    Liver; 1997 Feb; 17(1):47-52. PubMed ID: 9062880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene.
    Tsuda H; Satarug S; Bhudhisawasdi V; Kihana T; Sugimura T; Hirohashi S
    Mol Carcinog; 1992; 6(4):266-9. PubMed ID: 1336666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a new rat cell line established from 2'AAF-induced combined hepatocellular cholangiocellular carcinoma.
    Gil-Benso R; Martinez-Lorente A; Pellin-Perez A; Navarro-Fos S; Gregori-Romero MA; Carda C; Callaghan R; Peydro-Olaya A; Llombart-Bosch A
    In Vitro Cell Dev Biol Anim; 2001 Jan; 37(1):17-25. PubMed ID: 11249201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
    Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
    J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate-cell carcinoma?
    Malvi D; de Biase D; Fittipaldi S; Grillini M; Visani M; Pession A; D'Errico A; Vasuri F
    Histopathology; 2020 Jan; 76(2):265-274. PubMed ID: 31374137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characteristics of fibrolamellar hepatocellular carcinoma.
    Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Törzsök P; Kovalszky I; Barbai T; Rásó E; Lotz G; Schaff Z; Kiss A
    Pathol Oncol Res; 2013 Jan; 19(1):63-70. PubMed ID: 22872444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent k- ras -2 mutations and p16(INK4A)methylation in hepatocellular carcinomas in workers exposed to vinyl chloride.
    Weihrauch M; Benicke M; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
    Br J Cancer; 2001 Apr; 84(7):982-9. PubMed ID: 11286481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant liver disease in alpha 1-antitrypsin deficiency.
    Poley JR
    Acta Paediatr Suppl; 1994 Feb; 393():27-32. PubMed ID: 8032114
    [No Abstract]   [Full Text] [Related]  

  • 35. Alterations of the Rb gene and its association with Ki-ras activation and p53 inactivation in endometrial adenocarcinoma.
    Enomoto T; Fujita M; Inoue M; Nakazawa-Miyamoto A; Tanizawa O; Nomura T
    Mol Carcinog; 1993; 8(3):132-7. PubMed ID: 8105795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
    Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
    Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings.
    Aoki K; Takayasu K; Kawano T; Muramatsu Y; Moriyama N; Wakao F; Yamamoto J; Shimada K; Takayama T; Kosuge T
    Hepatology; 1993 Nov; 18(5):1090-5. PubMed ID: 7693572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
    J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma in patients from northern Sweden with acute intermittent porphyria: morphology and mutations.
    Bjersing L; Andersson C; Lithner F
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):393-7. PubMed ID: 9162306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components.
    Han B; Mori I; Wang X; Nakamura M; Nakamura Y; Kakudo K
    Int J Exp Pathol; 2005 Aug; 86(4):213-8. PubMed ID: 16045543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.